Lsl Pharma Group Inc (LSL.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 09-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,509 | 1,129 | 1,047 | 974 | 373 |
| Income taxes - deferred | 50 | N/A | N/A | 147 | -5 |
| Accounts receivable | -508 | N/A | N/A | 965 | -364 |
| Other Working Capital | -3,985 | -4,740 | 2,971 | -1,994 | -385 |
| Other Operating Activity | 1,282 | -3,459 | -7,182 | -1,178 | 263 |
| Operating Cash Flow | $-1,652 | $-7,070 | $-3,164 | $-1,085 | $-118 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,121 | -656 | -997 | -915 | -86 |
| Net Acquisitions | -3,255 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -1,080 | -361 | 0 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | -125 | -1,108 |
| Investing Cash Flow | $-7,456 | $-1,017 | $-997 | $-1,040 | $-1,194 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 395 | 195 | 500 | N/A | N/A |
| Debt Issued | 8,755 | 4,573 | 3,460 | 5,320 | 40 |
| Debt Repayment | -5,636 | -2,785 | -1,136 | -4,770 | -289 |
| Common Stock Issued | 8,230 | 9,463 | 2,367 | 2,645 | 3,225 |
| Other Financing Activity | -2,348 | -3,351 | -1,771 | -2,254 | -1,235 |
| Financing Cash Flow | $9,396 | $8,095 | $3,420 | $940 | $1,741 |
| Beginning Cash Position | 8 | 0 | 741 | 1,925 | 33 |
| End Cash Position | 296 | 8 | 0 | 741 | 462 |
| Net Cash Flow | $288 | $8 | $-741 | $-1,184 | $429 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,652 | -7,070 | -3,164 | -1,085 | -118 |
| Capital Expenditure | -4,201 | -1,017 | -997 | -915 | -86 |
| Free Cash Flow | -5,853 | -8,087 | -4,161 | -2,000 | -203 |